Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome.

Radin M, Foddai SG, Cecchi I, Rubini E, Schreiber K, Roccatello D, Bertolaccini ML, Sciascia S.

Thromb Haemost. 2020 Mar 17. doi: 10.1055/s-0040-1705115. [Epub ahead of print]

PMID:
32185783
2.

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.

Radin M, Cecchi I, Schreiber K, Rubini E, Roccatello D, Cuadrado MJ, Sciascia S.

Semin Arthritis Rheum. 2020 Jan 28. pii: S0049-0172(20)30007-X. doi: 10.1016/j.semarthrit.2020.01.007. [Epub ahead of print]

PMID:
32089355
3.

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.

Cecchi I, Perez-Sanchez C, Sciascia S, Radin M, Arias de la Rosa I, Barbarroja Puerto N, Scudeler L, Perez-Sanchez L, Patiño Trives AM, Aguirre Zamorano MA, Menegatti E, Roccatello D, Lopez-Pedrera C.

Autoimmun Rev. 2020 Apr;19(4):102488. doi: 10.1016/j.autrev.2020.102488. Epub 2020 Feb 13. No abstract available.

PMID:
32062026
4.

Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis.

Sciascia S, Radin M, Cecchi I, Fenoglio R, De Marchi A, Besso L, Baldovino S, Rossi D, Miraglia P, Rubini E, Roccatello D.

J Nephrol. 2020 Jan 23. doi: 10.1007/s40620-019-00698-9. [Epub ahead of print]

PMID:
31974856
5.

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.

Arias de la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Patiño-Trives A, Torres-Granados C, Jimenez-Gomez Y, Abalos-Aguilera MDC, Cecchi I, Ortega R, Caracuel MA, Calvo-Gutierrez J, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.

Haematologica. 2020 Jan 16. pii: haematol.2018.205047. doi: 10.3324/haematol.2018.205047. [Epub ahead of print]

6.

A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution.

Radin M, Schreiber K, Cecchi I, Bortoluzzi A, Crisafulli F, de Freitas CM, Bacco B, Rubini E, Foddai SG, Padovan M, Gallo Cassarino S, Franceschini F, Andrade D, Benedetto C, Govoni M, Bertero T, Marozio L, Roccatello D, Andreoli L, Sciascia S.

Rheumatology (Oxford). 2020 Jan 14. pii: kez620. doi: 10.1093/rheumatology/kez620. [Epub ahead of print]

PMID:
31943123
7.

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.

Sciascia S, Radin M, Cecchi I, Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M, Giachino O, Baldovino S, Rossi D, Mengozzi G, Roccatello D.

Rheumatology (Oxford). 2019 Dec 16. pii: kez596. doi: 10.1093/rheumatology/kez596. [Epub ahead of print]

PMID:
31840749
8.

Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring.

Sciascia S, Cecchi I, Massara C, Rossi D, Radin M, Ladehesa PL, Guiñazu F, Rubini E, Foddai SG, Alba P, Escudero A, Menegatti E, Roccatello D.

Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12. Review. No abstract available.

PMID:
31838167
9.

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients.

Sciascia S, Cecchi I, Radin M, Rubini E, Suárez A, Roccatello D, Rodríguez-Carrio J.

Front Med (Lausanne). 2019 Sep 26;6:211. doi: 10.3389/fmed.2019.00211. eCollection 2019.

10.

Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study.

Radin M, Schreiber K, Sciascia S, Roccatello D, Cecchi I, Aguirre Zamorano MÁ, Cuadrado MJ.

Thromb Haemost. 2019 Dec;119(12):1920-1926. doi: 10.1055/s-0039-1696687. Epub 2019 Oct 6.

PMID:
31587246
11.

The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience.

Radin M, Sciascia S, Cecchi I, Mengozzi G, Roccatello D.

Eur J Intern Med. 2019 Oct;68:e12-e14. doi: 10.1016/j.ejim.2019.07.026. Epub 2019 Aug 2. No abstract available.

PMID:
31378436
12.

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.

Pérez-Sánchez C, Cecchi I, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Pérez-Sánchez L, Ibáñez-Costa A, Arias de la Rosa I, Ortega R, Escudero A, Castro MC, Radin M, Roccatello D, Sciascia S, Aguirre MÁ, Collantes E, López-Pedrera C; BIOSAR Study Group.

J Cell Mol Med. 2019 Sep;23(9):6308-6318. doi: 10.1111/jcmm.14517. Epub 2019 Jul 26.

13.

Pregnancy outcomes in mixed connective tissue disease: a multicentre study.

Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro T, Andrade D, Gibbone E, Khamashta M, Buyon J, Izmirly P, Aguirre MA, Benedetto C, Roccatello D, Marozio L, Sciascia S.

Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141.

PMID:
31079145
14.

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS.

Arias de la Rosa I, Radin M, Cecchi I, Rubini E, Pérez-Sánchez C, Aguirre MÁ, Menegatti E, Barbarroja N, Collantes E, Sciascia S, Roccatello D, López Pedrera C.

Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166. No abstract available.

PMID:
31034051
15.

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.

Sciascia S, Radin M, Cecchi I, Rubini E, Scotta A, Rolla R, Montaruli B, Pergolini P, Mengozzi G, Muccini E, Baldovino S, Ferro M, Vaccarino A, Mahler M, Menegatti E, Roccatello D.

Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.

16.

ASIA Syndrome Following Breast Implant Placement.

Fenoglio R, Cecchi I, Roccatello D.

Isr Med Assoc J. 2018 Nov;20(11):714-716. No abstract available.

17.

Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Cecchi I, Pérez Sánchez L, Sciascia S, Roccatello D.

BMJ Case Rep. 2018 Nov 1;2018. pii: bcr-2018-225532. doi: 10.1136/bcr-2018-225532.

PMID:
30389732
18.

Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.

Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.

Autoimmun Rev. 2018 Nov;17(11):1138-1149. doi: 10.1016/j.autrev.2018.06.006. Epub 2018 Sep 11. Review.

PMID:
30217550
19.

Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients.

Radin M, Cecchi I, Rubini E, Schreiber K, Roccatello D, Mahler M, Sciascia S.

Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2. No abstract available.

PMID:
30096511
20.

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab.

Sciascia S, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D.

Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18. No abstract available.

21.

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome.

Sciascia S, Radin M, Cecchi I, Rubini E, Bazzan M, Roccatello D.

Semin Arthritis Rheum. 2019 Feb;48(4):741-744. doi: 10.1016/j.semarthrit.2018.04.001. Epub 2018 Apr 11.

22.

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.

Pérez-Sánchez C, Arias-de la Rosa I, Aguirre MÁ, Luque-Tévar M, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, Ábalos-Aguilera MC, Collantes-Estévez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martínez C, González-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, López-Pedrera C.

Haematologica. 2018 May;103(5):908-918. doi: 10.3324/haematol.2017.184416. Epub 2018 Mar 15.

23.

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.

Arias de la Rosa I, Escudero-Contreras A, Rodríguez-Cuenca S, Ruiz-Ponce M, Jiménez-Gómez Y, Ruiz-Limón P, Pérez-Sánchez C, Ábalos-Aguilera MC, Cecchi I, Ortega R, Calvo J, Guzmán-Ruiz R, Malagón MM, Collantes-Estevez E, Vidal-Puig A, López-Pedrera C, Barbarroja N.

J Intern Med. 2018 Jul;284(1):61-77. doi: 10.1111/joim.12743. Epub 2018 Mar 12.

PMID:
29532531
24.

Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.

Sciascia S, Radin M, Sanna G, Cecchi I, Roccatello D, Bertolaccini ML.

Rheumatology (Oxford). 2018 Apr 1;57(4):661-665. doi: 10.1093/rheumatology/kex466. Review.

25.

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.

Radin M, Schreiber K, Cecchi I, Roccatello D, Cuadrado MJ, Sciascia S.

Eur J Neurol. 2018 Feb;25(2):320-325. doi: 10.1111/ene.13499. Epub 2017 Dec 2.

26.

Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review.

Radin M, Cecchi I, Roccatello D, Meroni PL, Sciascia S.

Semin Thromb Hemost. 2018 Jul;44(5):466-474. doi: 10.1055/s-0037-1603936. Epub 2017 Aug 4. Review.

PMID:
28778105
27.

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.

Pérez-Sánchez C, Aguirre MÁ, Ruiz-Limón P, Ábalos-Aguilera MC, Jiménez-Gómez Y, Arias-de la Rosa I, Rodriguez-Ariza A, Fernández-Del Río L, González-Reyes JA, Segui P, Collantes-Estévez E, Barbarroja N, Velasco F, Sciascia S, Cecchi I, Cuadrado MJ, Villalba JM, López-Pedrera C.

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1923-1932. doi: 10.1161/ATVBAHA.117.309225. Epub 2017 Jul 6.

PMID:
28684614
28.

Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

Radin M, Cecchi I, Pérez-Sánchez C.

Lupus. 2017 Nov;26(13):1457-1458. doi: 10.1177/0961203317711014. Epub 2017 May 22. No abstract available.

PMID:
28530465
29.

The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.

Radin M, Schreiber K, Costanzo P, Cecchi I, Roccatello D, Baldovino S, Bazzan M, Cuadrado MJ, Sciascia S.

Int J Cardiol. 2017 Aug 1;240:72-77. doi: 10.1016/j.ijcard.2017.02.155. Epub 2017 Mar 24.

30.

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D, Dall'Era M.

Rheumatol Int. 2017 Aug;37(8):1249-1255. doi: 10.1007/s00296-017-3686-5. Epub 2017 Mar 3. Review.

31.

Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.

Sciascia S, Lopez-Pedrera C, Cecchi I, Pecoraro C, Roccatello D, Cuadrado MJ.

Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Epub 2016 Feb 3. Review.

Supplemental Content

Loading ...
Support Center